Genentech Biooncology
Genentech Biooncology
    • Home 

    • Research Education 

    • Research B cell 

    • Fundamental concepts in B-cell malignancies 

    • Programmed cell death 

    • Direct cell death 

    • GLOSSARY
    • ON
    • OFF
  • Print
  • share
 
 
' The related resources bookmark allows you to jump directly to other pages on the site that contain information directly related to the topics you're currently exploring.
  • Home Page
  • What's New?
  • Tumor Types
  • Molecular Causes of Cancer
  • Biological Pathways
  • Therapeutic Targets
  • Pipeline Molecules
  • Research Education
    • Research ADCs
    • Research Apoptosis
    • Research B cell
      • Glycoengineering
      • Fundamental concepts in B-cell malignancies
        • Cellular characteristics
        • Programmed cell death
          • Extrinsic pathway
          • Intrinsic pathway
          • Direct cell death
        • Cell proliferation signals
        • Dysregulation of the cell cycle
        • References
      • Chronic lymphocytic leukemia (CLL)
      • Follicular non-Hodgkin's lymphoma (fNHL)
      • Diffuse large B-cell lymphoma (DLBCL)
      • Slide decks, videos and downloads
    • Research BRAF
    • Research HDIs
    • Research HER Pathways
    • Research MET
    • Research VEGF
  • Clinical Trials
  • Resources
  • Contact Us
Register for Updates Unsubscribe Share
Register for Updates Unsubscribe Share

Related Resources for this page:

  • Tumor Types
    • CLL
      • CLL
    • DLBCL
      • DLBCL
    • fNHL
      • Follicular Lymphoma
  • Biological Pathways
    • Apoptotic Signaling
      • Apoptosis
    • Bcell Surface Proteins
      • B-cell Surface Proteins
  • Future Directions
    • Antibody-Drug conjugates
      • Emerging therapeutic options
      • Emerging therapeutic options
      • HER Signaling
      • Glossary
      • Receptor-Mediated Endocytosis
    • Apoptosis
      • Emerging therapeutic options
    • Bispecific Monoclonal Antibodies
      • Emerging therapeutic options
      • Emerging therapeutic options
      • Emerging therapeutic options
    • Glycoengineered Antibodies
      • Emerging therapeutic options
      • Emerging therapeutic options
      • HER Signaling
      • Emerging therapeutic options
      • Current research in glycoengineering
    • Non-Antibody Biologics
      • Apoptosis
      • Extrinsic pathway
    • Targeted Small Molecules
      • Apoptosis
      • Apoptotic pathways
      • The Bcl-2 family
      • Apoptosis
      • Emerging therapeutic options
      • Emerging therapeutic options
      • Resisting apoptosis
      • Gastric Cancer
      • Glossary
      • MAPK Signaling
      • MEK Inhibitor (GDC-0973)
      • Emerging therapeutic options
      • PI3K Inhibitor (GDC-0941)
      • Reactivating apoptosis
      • PI3K/Akt/mTOR Signaling
    • Traditional Monoclonal Antibodies
      • B-cell Surface Proteins
      • Glossary
      • Emerging therapeutic options
      • Emerging therapeutic options
      • The evolving CLL treatment landscape
      • Gastric Cancer
      • HER Signaling
      • Emerging therapeutic options
Share

Direct cell death

  • A distinct mechanism for tumor destruction known as direct cell death has been identified and is an area of active research. This form of cell death involves homotypic cellular adhesion followed by non-autophagic lysosome–mediated cell death11
    • Some monoclonal antibodies evaluated for the treatment of B-cell malignancies have been shown to induce enhanced direct cell death in vitro

View References for this site section

 
  • SITEMAP
  • /
  • PRIVACY POLICY
  • /
  • TERMS & CONDITIONS
  • /
  • CONTACT US
  • /
  • © 2013 Genentech USA, Inc. All rights reserved.
  • /
  • BIO0000907901
Next section: Cell proliferation signals »

© 2011 Genentech USA, Inc. All rights reserved